2025
SJR Q3
JCR Q4 · 1,5
30 matched articles
SCIE
Journal detail
Viral Immunology
- Publisher
- Mary Ann Liebert Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0882824515578976
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,438
- Quartile Q3
- H-Index 73
- Cites/doc 1,43
- Docs (3y) 213
- Cites (3y) 276
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,5
- 5Y JIF 1,4
- JCI 0,31
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Immunology Q4
- Molecular Medicine Q4
- Virology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
WoS categories
- Immunology | Virology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,438 | 1,5 | 1,4 | 0,31 | Q4 | 73 |
| 2024 | Q3 | Q4 | 0,349 | 1,2 | 1,4 | 0,31 | Q4 | 71 |
| 2023 | Q3 | Q4 | 0,441 | 1,5 | 2,5 | 0,33 | Q4 | 71 |
| 2022 | Q3 | Q4 | 0,559 | 2,2 | 2,2 | 0,36 | Q4 | 71 |
| 2021 | Q3 | Q4 | 0,723 | 2,2 | 2,2 | 0,36 | Q4 | 71 |
| 2020 | Q3 | Q4 | 0,777 | 2,3 | 1,9 | 0,44 | Q4 | 71 |
| 2019 | Q3 | Q4 | 0,665 | 1,7 | 1,5 | 0,41 | Q4 | 71 |
| 2018 | — | Q4 | — | 1,4 | 1,4 | 0,38 | Q4 | — |
| 2017 | Q3 | Q4 | 0,677 | 1,5 | 1,5 | 0,38 | Q4 | 71 |
| 2016 | Q3 | Q4 | 0,705 | 1,4 | 1,4 | — | — | 71 |
| 2015 | Q3 | Q4 | 0,755 | 1,5 | 1,5 | — | — | 71 |
| 2014 | Q3 | Q4 | 0,686 | 1,4 | 1,6 | — | — | 71 |
| 2013 | Q3 | Q4 | 0,938 | 1,6 | 1,9 | — | — | 71 |
| 2012 | Q3 | Q4 | 0,855 | 1,8 | 1,8 | — | — | 71 |
| 2011 | Q2 | Q3 | 0,884 | 2 | 1,9 | — | — | 71 |
| 2010 | Q2 | Q3 | 0,847 | 1,9 | 1,9 | — | — | 71 |
| 2009 | — | Q4 | — | 1,8 | 2,2 | — | — | — |
| 2008 | — | Q3 | — | 1,9 | 2,2 | — | — | — |
| 2007 | — | Q3 | — | 1,8 | 2,2 | — | — | — |
| 2006 | — | Q3 | — | 2,1 | — | — | — | — |
| 2005 | — | Q3 | — | 2 | — | — | — | — |
| 2004 | — | Q2 | — | 2,2 | — | — | — | — |
| 2003 | — | Q3 | — | 1,9 | — | — | — | — |
| 2002 | — | Q3 | — | 1,6 | — | — | — | — |
| 2001 | — | Q3 | — | 1,2 | — | — | — | — |
| 2000 | — | Q4 | — | 1 | — | — | — | — |
| 1999 | — | Q3 | — | 1,3 | — | — | — | — |
| 1998 | — | Q3 | — | 1,3 | — | — | — | — |
| 1997 | — | Q3 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q4 | Q4 | 160/183 |
| 2025 | VIROLOGY | SCIE | Q4 | Q4 | 37/44 |
| 2024 | IMMUNOLOGY | SCIE | Q4 | Q4 | 164/183 |
| 2024 | VIROLOGY | SCIE | Q4 | Q4 | 37/42 |
| 2023 | IMMUNOLOGY | SCIE | Q4 | Q4 | 154/181 |
| 2023 | VIROLOGY | SCIE | Q4 | Q4 | 35/41 |
| 2022 | IMMUNOLOGY | SCIE | Q4 | Q4 | 137/161 |
| 2022 | VIROLOGY | SCIE | Q4 | Q4 | 29/36 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q4 | 146/162 |
| 2021 | VIROLOGY | SCIE | Q4 | Q4 | 31/37 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q4 | 138/162 |
| 2020 | VIROLOGY | SCIE | Q4 | Q4 | 30/37 |
| 2019 | IMMUNOLOGY | SCIE | Q4 | Q4 | 135/159 |
| 2019 | VIROLOGY | SCIE | Q4 | Q4 | 32/37 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q4 | 142/158 |
| 2018 | VIROLOGY | SCIE | Q4 | Q4 | 30/36 |
| 2017 | IMMUNOLOGY | SCIE | Q4 | Q4 | 137/155 |
| 2017 | VIROLOGY | SCIE | Q4 | Q4 | 30/35 |
| 2016 | IMMUNOLOGY | SCIE | Q4 | — | 134/151 |
| 2016 | VIROLOGY | SCIE | Q4 | — | 28/34 |
| 2015 | IMMUNOLOGY | SCIE | Q4 | — | 133/151 |
| 2015 | VIROLOGY | SCIE | Q4 | — | 27/33 |
| 2014 | IMMUNOLOGY | SCIE | Q4 | — | 129/148 |
| 2014 | VIROLOGY | SCIE | Q4 | — | 29/33 |
| 2013 | IMMUNOLOGY | SCIE | Q4 | — | 124/144 |
| 2013 | VIROLOGY | SCIE | Q4 | — | 29/33 |
| 2012 | IMMUNOLOGY | SCIE | Q4 | — | 111/137 |
| 2012 | VIROLOGY | SCIE | Q4 | — | 28/34 |
| 2011 | IMMUNOLOGY | SCIE | Q4 | — | 106/139 |
| 2011 | VIROLOGY | SCIE | Q3 | — | 24/32 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 105/134 |
| 2010 | VIROLOGY | SCIE | Q3 | — | 24/33 |
| 2009 | IMMUNOLOGY | SCIE | Q4 | — | 101/128 |
| 2009 | VIROLOGY | SCIE | Q4 | — | 23/30 |
| 2008 | IMMUNOLOGY | SCIE | Q3 | — | 88/121 |
| 2008 | VIROLOGY | SCIE | Q3 | — | 20/27 |
| 2007 | IMMUNOLOGY | SCIE | Q3 | — | 89/119 |
| 2007 | VIROLOGY | SCIE | Q4 | — | 22/25 |
| 2006 | IMMUNOLOGY | SCIE | Q3 | — | 73/117 |
| 2006 | VIROLOGY | SCIE | Q4 | — | 18/23 |
| 2005 | IMMUNOLOGY | SCIE | Q3 | — | 70/115 |
| 2005 | VIROLOGY | SCIE | Q4 | — | 18/23 |
| 2004 | IMMUNOLOGY | SCIE | Q2 | — | 52/111 |
| 2004 | VIROLOGY | SCIE | Q3 | — | 15/22 |
| 2003 | IMMUNOLOGY | SCIE | Q3 | — | 62/114 |
| 2003 | VIROLOGY | SCIE | Q3 | — | 17/23 |
| 2002 | IMMUNOLOGY | SCIE | Q3 | — | 74/119 |
| 2002 | VIROLOGY | SCIE | Q4 | — | 19/24 |
| 2001 | IMMUNOLOGY | SCIE | Q3 | — | 81/114 |
| 2001 | VIROLOGY | SCIE | Q4 | — | 22/25 |
| 2000 | IMMUNOLOGY | SCIE | Q4 | — | 91/116 |
| 2000 | VIROLOGY | SCIE | Q4 | — | 24/28 |
| 1999 | IMMUNOLOGY | SCIE | Q3 | — | 77/115 |
| 1999 | VIROLOGY | SCIE | Q3 | — | 19/26 |
| 1998 | IMMUNOLOGY | SCIE | Q3 | — | 71/120 |
| 1998 | VIROLOGY | SCIE | Q3 | — | 17/25 |
| 1997 | IMMUNOLOGY | SCIE | Q3 | — | 82/117 |
| 1997 | VIROLOGY | SCIE | Q4 | — | 19/24 |